Published online Feb 28, 2022. doi: 10.13105/wjma.v10.i1.37
Peer-review started: November 22, 2021
First decision: December 10, 2021
Revised: December 17, 2021
Accepted: January 27, 2022
Article in press: January 27, 2022
Published online: February 28, 2022
Processing time: 97 Days and 16.5 Hours
Unexplained infertility (UI) is usually used for any heterosexual couple who failed to have a successful clinical pregnancy without identifying clear causes after they undergo all standard fertility tests. Evidence shows that leptin is one of the most accurate biomarkers for UI. Nevertheless, conflicting results regarding leptin levels in women with UI have been reported.
To find the serum leptin levels in women with UI.
All studies written in English and conducted before April 30, 2021 from PubMed/MEDLINE, Embase, Cochrane Central Register of Controlled Trials, ClinicalTrials.gov, Google Scholar, OpenGrey, OATD, and the infertility conference abstract were included. Studies were found eligible if they provided the mean and standard deviation of leptin for the case group and control group. The quality assessment of individual studies was evaluated using the Joanna Briggs Institute Quality Assessment Tool. Data synthesis and statistical analysis were done using STATA software version 16.
A total of 378 studies were reviewed, and just six studies that fulfilled the eligibility criteria were included in this meta-analysis. The pooled result showed that leptin levels were significantly higher in women with UI compared to fertile women, with a standardized mean difference of 0.97 (95% confidence interval: -0.49-2.43). However, heterogeneity across studies was highly significant (P < 0.00001; I2 = 98.8%).
The results of this study suggest that leptin levels are elevated in women with UI compared with fertile women; hence, leptin could be a potential biomarker for UI in women, and it may be useful for identifying women with a high risk of infertility.
Core Tip: A comprehensive systematic review and meta-analysis was conducted to find the serum leptin levels in women with unexplained infertility. Six studies were included in this meta-analysis, after passing all quality checkups. The pooled result showed that leptin levels were significantly higher in women with unexplained infertility compared to fertile women, with a standardized mean difference of 0.97. Leptin could be a potential biomarker for unexplained infertility in women, and it may be useful for identifying women with a high risk of infertility.